Clin Lab. 2024 Aug 1;70(8). doi: 10.7754/Clin.Lab.2024.240230.
Megaloblastic anemia is a subtype of anemia with increased red blood cell volume. These megaloblastic cells can be easily destroyed in the bone marrow and spleen, leading to ineffective hematopoiesis. Insulin-degrading enzymes (IDE) in erythrocytes can break down the insulin into amino acid fragments; thus, when hemolysis occurs, IDE can be released into the blood, resulting in low insulin measurement values.
This article reports a case of false insulin test results due to the hemolysis resulting from megaloblastic anemia.
The patient's first fasting glucose results indicated that the glucose and C-peptide levels were within the normal range while her insulin level was abnormally low. After hemolysis was corrected, the relevant indicators were re-evaluated and all the results were normal.
This article reports a patient diagnosed with megaloblastic anemia, whose dysmorphic erythrocytes cause severe extravascular hemolysis. It was the occurrence of hemolysis that the IDE released into the blood, leading to the abnormal insulin test result.
巨幼细胞性贫血是一种红细胞体积增大的贫血症亚型。这些巨幼细胞在骨髓和脾脏中很容易被破坏,导致无效造血。红细胞中的胰岛素降解酶(IDE)可以将胰岛素分解成氨基酸片段;因此,当发生溶血时,IDE 可以释放到血液中,导致胰岛素测量值降低。
本文报告了一例由于巨幼细胞性贫血引起的溶血导致胰岛素检测结果假性降低的病例。
患者的空腹血糖首次检查结果显示,其血糖和 C 肽水平均在正常范围内,而胰岛素水平异常降低。在纠正溶血后,重新评估了相关指标,结果均正常。
本文报告了一例诊断为巨幼细胞性贫血的患者,其形态异常的红细胞导致严重的血管外溶血。正是溶血的发生导致 IDE 释放到血液中,从而导致异常的胰岛素检测结果。